mozavaptan has been researched along with substance p in 1 studies
| Studies (mozavaptan) | Trials (mozavaptan) | Recent Studies (post-2010) (mozavaptan) | Studies (substance p) | Trials (substance p) | Recent Studies (post-2010) (substance p) |
|---|---|---|---|---|---|
| 165 | 8 | 24 | 17,289 | 277 | 2,010 |
| Protein | Taxonomy | mozavaptan (IC50) | substance p (IC50) |
|---|---|---|---|
| Substance-P receptor | Rattus norvegicus (Norway rat) | 0.0005 | |
| Substance-K receptor | Rattus norvegicus (Norway rat) | 0.2 | |
| Substance-K receptor | Homo sapiens (human) | 0.2455 | |
| Substance-P receptor | Homo sapiens (human) | 0.0011 | |
| Neuromedin-K receptor | Homo sapiens (human) | 0.125 | |
| Substance-K receptor | Mesocricetus auratus (golden hamster) | 0.148 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamiya, H; Matsumoto, T; Nakayama, Y; Saigo, A; Saito, R; Takano, Y; Tran, M; Yamada, K | 1 |
1 other study(ies) available for mozavaptan and substance p
| Article | Year |
|---|---|
Central administration of senktide, a tachykinin NK-3 agonist, has an antidiuretic action by stimulating AVP release in water-loaded rats.
Topics: Animals; Arginine Vasopressin; Benzazepines; Diuresis; Injections, Intraventricular; Male; Peptide Fragments; Rats; Rats, Wistar; Receptors, Neurokinin-3; Substance P; Urodynamics; Water | 1993 |